BioCentury
ARTICLE | Clinical News

Fycompa perampanel regulatory update

May 9, 2016 7:00 AM UTC

FDA approved Fycompa perampanel oral suspension from Eisai as an adjunctive therapy in the treatment of partial-onset seizures, with or without secondarily generalized seizures, and primary generalize...